T CELL AND B CELL RECEPTOR SEQUENCING REVEALS ANTI-CANCER IMMUNE RESPONSE ASSOCIATED WITH IMMUNE-RELATED ADVERSE EVENTS IN ADVANCED RENAL CELL CARCINOMA PATIENTS TREATED WITH IMMUNE CHECKPOINT INHIBITORS

被引：0
|
作者：
Kato, Taigo
Kiyotani, Kazuma
Ishizuya, Yu
Yamamoto, Yoshiyuki
Hatano, Koji
Kawashima, Atsunari
Nonomura, Norio
机构：
来源：
JOURNAL OF UROLOGY | 2023年 / 209卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学]; R69 [泌尿科学（泌尿生殖系疾病）];
学科分类号：
1002 ; 100201 ;
摘要：
MP04-14
引用
收藏
页码：E38 / E39
页数：2
相关论文
共 50 条
  • [11] Association between Immune Related Adverse Events and Outcome in Patients with Metastatic Renal Cell Carcinoma Treated with Immune Checkpoint Inhibitors
    Paderi, Agnese
    Giorgione, Roberta
    Giommoni, Elisa
    Mela, Marinella Micol
    Rossi, Virginia
    Doni, Laura
    Minervini, Andrea
    Carini, Marco
    Pillozzi, Serena
    Antonuzzo, Lorenzo
    CANCERS, 2021, 13 (04) : 1 - 11
  • [12] Delayed immune-related adverse events in patients with advanced melanoma treated with immune checkpoint inhibitors
    Angeles, Arkhjamil
    Sonke, Eric
    Thao Phuong Nguyen
    Bahl, Gaurav
    Poon, Vincent Isaac
    Bernstein, Vanessa
    Weppler, Alison Margaret
    Savage, Kerry J.
    JOURNAL OF CLINICAL ONCOLOGY, 2024, 42 (16)
  • [13] Correlation of immune-related adverse events and response from immune checkpoint inhibitors in patients with advanced non-small cell lung cancer
    Sung, Mike
    Zer, Mona
    Walia, Preet
    Khoja, Leila
    Maganti, Manjula
    Labbe, Catherine
    Shepherd, Frances A.
    Bradbury, Penelope A.
    Liu, Geoffrey
    Leighl, Natasha B.
    JOURNAL OF THORACIC DISEASE, 2020, 12 (05) : 2706 - 2712
  • [14] Immune-Related Adverse Events Associated with Immune Checkpoint Inhibitors
    Daphne Day
    Aaron R. Hansen
    BioDrugs, 2016, 30 : 571 - 584
  • [15] Immune-Related Adverse Events Associated with Immune Checkpoint Inhibitors
    Day, Daphne
    Hansen, Aaron R.
    BIODRUGS, 2016, 30 (06) : 571 - 584
  • [16] T-Cell Receptor Repertoire as a Predictor of Immune-Related Adverse Events in Renal Cell Carcinoma
    Kobayashi, Takuro
    Nagata, Masayoshi
    Ikehata, Yoshihiro
    Nagashima, Yuki
    Nagaya, Naoya
    Lu, Yan
    Horie, Shigeo
    CURRENT ISSUES IN MOLECULAR BIOLOGY, 2023, 45 (11) : 8939 - 8949
  • [17] B-cell receptor repertoire analysis predict immune-related adverse events following immune checkpoint inhibitors
    Yoshimura, Akihiro
    Kato, Taigo
    Nemoto, Kensaku
    Kanaki, Tomohiro
    Liu, Yutong
    Tani, Masaru
    Oka, Toshiki
    Okuda, Yohei
    Yamamichi, Gaku
    Ishizuya, Yu
    Yamamoto, Yoshiyuki
    Hayashi, Takuji
    Hatano, Koji
    Kawashima, Atsunari
    Kiyotani, Kazuma
    Nonomura, Norio
    CANCER SCIENCE, 2025, 116 : 968 - 968
  • [18] Immune-Related Adverse Events and Clinical Outcomes in Advanced Urothelial Cancer Patients Treated With Immune Checkpoint Inhibitors
    Sanda, Gregory E.
    Shabto, Julie M.
    Goyal, Subir
    Liu, Yuan
    Martini, Dylan J.
    Nazha, Bassel
    Brown, Jacqueline T.
    Yantorni, Lauren B.
    Russler, Greta Anne
    Caulfield, Sarah
    Joshi, Shreyas S.
    Narayan, Vikram M.
    Kissick, Haydn
    Ogan, Kenneth
    Master, Viraj A.
    Carthon, Bradley C.
    Kucuk, Omer
    Bilen, Mehmet Asim
    ONCOLOGIST, 2023, : 1072 - 1078
  • [19] ASSOCIATION OF IMMUNE RELATED ADVERSE EVENTS WITH THE EFFICACY OF IMMUNE CHECKPOINT INHIBITORS IN METASTATIC RENAL CELL CARCINOMA
    Bushunow, Vasilii
    Appleman, Leonard
    Thomas, Roby
    JOURNAL FOR IMMUNOTHERAPY OF CANCER, 2020, 8 : A112 - A113
  • [20] Oral manifestations of immune-related adverse events in cancer patients treated with immune checkpoint inhibitors
    Klein, Brittany A.
    Alves, Fabio Abreu
    de Santana Rodrigues Velho, Julia
    Vacharotayangul, Piamkamon
    Hanna, Glenn J.
    LeBoeuf, Nicole R.
    Shazib, Muhammad Ali
    Villa, Alessandro
    Woo, Sook-Bin
    Sroussi, Herve
    Sonis, Stephen
    Treister, Nathaniel S.
    ORAL DISEASES, 2022, 28 (01) : 9 - 22
12345